Palmitic acid stimulates energy metabolism and inhibits insulin/PI3K/AKT signaling in differentiated human neuroblastoma cells: The role of mTOR activation and mitochondrial ROS production

Neurochem Int. 2017 Nov:110:75-83. doi: 10.1016/j.neuint.2017.09.008. Epub 2017 Sep 15.

Abstract

The high consumption of saturated lipids has been largely associated with the increasing prevalence of metabolic diseases. In particular, saturated fatty acids such as palmitic acid (PA) have been implicated in the development of insulin resistance in peripheral tissues. However, how neurons develop insulin resistance in response to lipid overload is not fully understood. Here, we used cultured rat cortical neurons and differentiated human neuroblastoma cells to demonstrate that PA blocks insulin-induced metabolic activation, inhibits the activation of the insulin/PI3K/Akt pathway and activates mTOR kinase downstream of Akt. Despite the fact that fatty acids are not normally used as a significant source of fuel by neural cells, we also found that short-term neuronal exposure to PA reduces the NAD+/NADH ratio, indicating that PA modifies the neuronal energy balance. Finally, inhibiting mitochondrial ROS production with mitoTEMPO prevented the deleterious effect of PA on insulin signaling. This work provides novel evidence of the mechanisms behind saturated fatty acid-induced insulin resistance and its metabolic consequences on neuronal cells.

Keywords: Cortical neurons; Energy metabolism; Human neuroblastoma cells; Insulin resistance; Mitochondrial ROS; Palmitic acid; mTOR.

MeSH terms

  • Animals
  • Cell Differentiation / drug effects
  • Cell Differentiation / physiology
  • Cell Line, Tumor
  • Cells, Cultured
  • Energy Metabolism / drug effects
  • Energy Metabolism / physiology
  • Humans
  • Insulin / metabolism*
  • Insulin Antagonists / pharmacology
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Neuroblastoma / metabolism
  • Palmitic Acid / pharmacology*
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Phosphoinositide-3 Kinase Inhibitors
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Rats
  • Reactive Oxygen Species / metabolism*
  • Signal Transduction
  • TOR Serine-Threonine Kinases / metabolism*

Substances

  • Insulin
  • Insulin Antagonists
  • Phosphoinositide-3 Kinase Inhibitors
  • Reactive Oxygen Species
  • Palmitic Acid
  • MTOR protein, human
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases